Advanced Search
Users Online: 106
About
About Journal
Editorial Board
Articles
Ahead of Print
Current Issue
Archives
Authors
Submit Article
Instructions
Search
Advanced Search
Image Search
Medline Search
Special Issue
Subscribe
Contact Us
Login
Sign Up
Subscriber Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Table of Contents
January-March 2017
Volume 1 | Issue 1
Page Nos. 1-61
Online since Monday, July 17, 2017
Accessed 40,165 times.
View issue as eBook
Author Institution Mapping
Issue citations
Issue statistics
RSS
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
ORIGINAL ARTICLES
Effects of Dehydroepiandrosterone on Embryo Quality and Follicular Fluid Markers in Patients with Diminished Ovarian Reserves
p. 1
Jing Fu, Hua-Feng Jiang, Lu Li, Ai-Jie Xin, Yi-Juan Sun, Xiao-Xi Sun
DOI
:10.4103/2096-2924.210696
Background:
To examine the effects of dehydroepiandrosterone (DHEA) on
in vitro
fertilization (IVF) intracytoplasmic sperm injection (ICSI) and the levels of follicular fluid (FF) markers, namely, anti-Müllerian hormone (AMH), insulin-like growth factor (IGF)-1, bone morphogenetic protein (BMP)-15, and growth differentiation factor (GDF)-9, in patients with diminished ovarian reserves (DORs).
Methods:
116 patients with DOR were randomized into two groups, DHEA group and control group. Each group contained 58 patients. The DHEA group received 75 mg/d of DHEA for 12 weeks prior to the start of IVF treatment, while the control group entered IVF treatment directly. All patients were treated with the same ovarian stimulation protocol. The primary outcome was high-quality embryo yield. Other IVF parameters, such as the clinical pregnancy rate, embryo survival rate, and intact blastomere rate, were compared between the two groups. FF samples from patients of both groups were collected to measure the levels of AMH, IGF-1, DHEA-sulfate, BMP-15, and GDF-9. Blood was also collected on day 3 of the menstrual cycle to define the baseline hormonal profile and to examine ovarian reserve markers.
Results:
The high-quality embryo yield was higher in DHEA group than that in control group (
P
= 0.033). AMH and IGF-1 concentrations in FF were significantly higher in DHEA group than that in the control group (2.83 ± 1.14 ng/L vs. 1.37 ± 0.55 ng/L,
P
= 0.000; 94.02 ± 38.28 ng/L vs. 74.03 ± 25.46 ng/L,
P
= 0.004, respectively). The BMP-15 level was also higher in DHEA group (relative expression were 1.80 ± 0.41) than that in control group (relative expression were 0.79 ± 0.16,
P
< 0.0001); however, there was no difference in GDF-9 expression between the two groups (relative expression were 1.29 ± 0.54 and 1.16 ± 0.50 respectively,
P
> 0.05) and in the clinical pregnancy rate between the two groups (13.79% vs. 7.27%, respectively,
P
> 0.05).
Conclusions:
In women with DOR undergoing IVF treatment, pretreatment with DHEA may increase the number of high-quality embryos, which may be due to increased levels of AMH, IGF-1, and BMP-15 in the FF. Trial Registration: NCT02866253.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (2) ]
[Sword Plugin for Repository]
Beta
Analysis of the Fragile X Mental Retardation 1 Premutation in Han Chinese Women Presenting with Primary Ovarian Insufficiency
p. 9
Qing Chen, Qi-Qi Wang, Bao-Zhu Cai, Xiao-Jun Ren, Feng Zhang, Xiao-Jin Zhang
DOI
:10.4103/2096-2924.210692
Background:
The aim of this study is to investigate the prevalence of the fragile X mental retardation 1 (
FMR1
) gene premutation in Han Chinese women with primary ovarian insufficiency (POI) using a rapid and cost-effective method.
Methods:
A total of 153 Han Chinese women with sporadic POI were systematically analyzed for trinucleotide repeats within the
FMR1
gene. We employed an improved strategy to screen for cytosine-guanine-guanine repeats in the 5' untranslated region of the
FMR1
gene. Before using the previously reported FragilEase polymerase chain reaction (PCR) method for premutation identification, we developed a new cost-effective PCR-based method to exclude most of the normal allele carriers during the initial screening stage.
Results:
In our initial screening, 62.1% of women with POI were found to carry heterozygous normal alleles of
FMR1
, which were recognized by our sensitive and cost-effective method. The remaining women were further screened for the presence of the
FMR1
premutation. We identified a Han Chinese woman with a premutation allele of
FMR1
out of 153 sporadic POI women (0.7%).
Conclusions:
The frequent
FMR1
premutation in Caucasian individuals with POI may not be a common genetic cause of sporadic POI in the Han Chinese population.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (2) ]
[Sword Plugin for Repository]
Beta
REVIEW ARTICLES
Epigenetic Modification in Oocyte and Preimplantation Embryonic Development
p. 13
Yi-Xin Ren, William Chang, Jie Qiao
DOI
:10.4103/2096-2924.210694
DNA methylation and histone modification are two of the most characterized epigenetic modifications. With advanced detecting techniques, particularly single-cell sequencing, we can dissect epigenomic patterns and their regulatory roles in the growth and differentiation of gametes and early embryos in animals and humans. Assisted reproductive technology (ART) procedures have been shown to influence the methylation of certain genes. Aberrant epigenetic regulation may cause several developmental disorders and clinical diseases. Here, we describe some concepts in epigenetics and review recent researches on DNA methylation and the histone modification profile and their regulatory roles during early embryo development. We also summarize the recent progress in understanding the imprinting disorders associated with ART procedures.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (2) ]
[Sword Plugin for Repository]
Beta
Role of Related Regulatory Long Noncoding RNAs on Mammalian Spermatogenesis
p. 18
Kang-Sheng Liu, Xiao-Dong Mao, Feng Pan, Ling-Juan Gao, Xiu-Feng Ling
DOI
:10.4103/2096-2924.210690
Long noncoding RNAs (lncRNAs) are transcribed by RNA molecules, which are longer than 200 nucleotides that lack an open reading frame of significant length and possess no obvious protein-coding capacity. Studies have shown that lncRNAs participate in many physiological processes such as gene imprinting and X chromosome inactivation. They regulate gene expression mainly through DNA methylation, histone modification, and chromatin remodeling. LncRNAs can also affect the development of diseases, and they can be useful to diagnose and treat diseases. With the development of new sequencing and microarray techniques, hundreds of lncRNAs involved in spermatogenesis have been identified, but their functions in the testis are undefined. Herein, we will discuss the biology and regulation of lncRNAs, as well as the bioinformatics tools and searchable databases used to study them in the testis. We hope that this information will provide new insights in treating male reproductive diseases.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (1) ]
[Sword Plugin for Repository]
Beta
Biological Functions and Research Methods of Long Noncoding RNAs
p. 23
Jing Ma, Qing Chen, Duan Ma
DOI
:10.4103/2096-2924.210697
Long noncoding RNAs (lncRNAs) are functional RNA molecules which are longer than 200 nucleotides in length that do not encode proteins; instead, they regulate target gene expression at transcriptional, posttranscriptional, and epigenetic levels. LncRNAs play important roles in various biological processes such as dosage compensation, genomic imprinting, cell cycle regulation, and cell differentiation. Although their characterizations have been relatively straightforward with recent advances in modern biology, the functions of lncRNAs are largely unknown. Herein, we discuss the biological functions and research methods of lncRNAs.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Application of Single-cell Sequencing Technologies in Reproductive Medicine
p. 30
Peng Yuan, Li-Ying Yan, Jie Qiao
DOI
:10.4103/2096-2924.210691
We have recently witnessed the rapid development of various single-cell sequencing technologies. Pioneering single cell assays are now available for the profiling of genome, epigenome, and transcriptome. Single-cell sequencing technologies provide multi-dimensional information on early embryonic development in humans and in clinical contexts where specimens are scarce. Here, we review several available techniques and their applications in reproductive medicine. Continuing development of multimodal single-cell sequencing measurement techniques in combination with multi-omics assays will provide comprehensive profiles of an individual cell and lead to the targeted therapy for reproductive disorders and infertility.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Immune Regulation at Maternal-fetal Interface in Early Pregnancy
p. 36
Wen-Jie Zhou, Ming-Qing Li, Da-Jin Li
DOI
:10.4103/2096-2924.210695
Decidual immune cells (DICs), including T-cells, regulatory T-cells, macrophages/dendritic cells, natural killer cells, and neutrophils, are resident at the maternal–fetal interface, and play vital roles in regulating trophoblast migration, decidual angiogenesis, immune tolerance, placentation, and decidualization during the early pregnancy. Extensive researches have revealed that these maternal DICs cooperated with each other, or with maternal decidual stromal cells, or with fetal-derived trophoblasts, and further formed a special maternal-fetal cross talk at the maternal-fetal interface, which was essential for the construction and maintenance of physiological pregnancy. Once aberrant cross talk and immune regulation arise, many pregnancy complications will inevitably occur, such as spontaneous abortion, intrauterine growth restriction(IUGR), preeclampsia (PE), and preterm birth. Here, we reviewed how critical immune cells are either enriched or excluded from the decidua, how their function is regulated within the decidua, and how they variously contribute to pregnancy success or failure.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Mitochondrial Dysfunction and Age - related Oocyte Quality
p. 45
Han Li, Ri-Cheng Chian
DOI
:10.4103/2096-2924.210693
Fertility disorders have become a growing problem worldwide. It is well known that female fertility decreases with age, previous studies suggested that the age-related decline in female fertility potential was largely due to decrease in oocyte quality and mitochondrial dysfunction. Mitochondria play a crucial role during the process of oocyte maturation. Mitochondrial genetic, numerical and structural defects occur in oocyte aging process, mitochondrial abnormalities are believed to contribute to age-related infertility. Improvement of the mitochondrial function can lead to better fertility outcomes, and application of mitochondria replacement strategy or mitochondrial transfer to age-related infertility will be possible in the future. This review paper, we are trying to discuss current understanding about age-related changes in oocyte quality and mitochondrial dysfunction.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (2) ]
[Sword Plugin for Repository]
Beta
Estrogen Biosynthesis and Its Regulation in Endometriosis
p. 55
Qiu-Ming Qi, Sun-Wei Guo, Xi-Shi Liu
DOI
:10.4103/2096-2924.210698
Endometriosis is a common benign gynecological disorder with an enigmatic etiology and pathogenesis. It affects approximately 10% women of reproductive age. Although its etiology and pathogenesis remain poorly understood, it is characterized by the elevated local production of estrogen in the endometriotic tissues. In this paper, we review the mechanisms of estrogen biosynthesis and its regulation in endometriosis.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (6) ]
[Sword Plugin for Repository]
Beta
Next Issue
Previous Issue
SUBMIT ARTICLE
SUBSCRIBE
POPULAR ARTICLES
JOIN AS REVIEWER
GET EMAIL ALERTS
RECOMMEND
© Reproductive and Developmental Medicine | Published by Wolters Kluwer -
Medknow
Sitemap
|
What's New
|
Feedback
|
Disclaimer
|
Privacy Notice
Online since 7
th
February, 2017